🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603
Daprodustat has demonstrated an ability to effectively raise hemoglobin con...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-01-10
Trial ID
NCT03446612
The purpose of this multi-center study is to evaluate the efficacy and safe...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-11
Trial ID
NCT03029208
Treatments Being Tested
Absorption, metabolism and excretion of daprodustat (GSK1278863) have been ...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-10-10
Trial ID
NCT03239522
This study is intended to evaluate the dose-response relationship of GSK127...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-01
Trial ID
NCT01977482
Treatments Being Tested
This is a Phase III, open-label, active-controlled, parallel-group, multi-c...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-06
Trial ID
NCT02791763
Treatments Being Tested
Investigator-initiated, interventional, prospective study to assess the cli...
Status
Completed
Location
USRC Kidney Research
Start Date
2023-07-01
Trial ID
NCT05951192
Treatments Being Tested
This will be an open-label, randomized, parallel-group study in hemodialysi...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-07-27
Trial ID
NCT03029247
Treatments Being Tested
This 24-week, Phase 3, open-label, non-comparative, multicentre study aims ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-08
Trial ID
NCT02829320
Treatments Being Tested
Daprodustat is a drug that is currently being developed as a treatment for ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-11-21
Trial ID
NCT02969655